Please provide your email address to receive an email when new articles are posted on . Early cytomegalovirus reactivation after allogeneic stem cell transplantation induced cytomegalovirus ...
Cytomegalovirus (CMV), a common virus in the Herpesviridae family, infects approximately half of all adults in the United States, most of whom experience mild or no symptoms. While the virus usually ...
The results of multicenter phase II, double-blind placebo-controlled trial of maintenance ixazomib after allogeneic hematopoietic cell transplantation (alloHCT) for high-risk multiple myeloma (MM) ...
When we get infected with a virus, we typically expect our immune system to work hard to clear all pathogenic particles within a few days. What happens when the immune system isn’t able to get rid of ...
Fortress Biotech, Inc. and its subsidiary Helocyte, Inc. have initiated a Phase 2 clinical trial to assess the efficacy of the Triplex vaccine, designed to prevent cytomegalovirus (CMV) reactivation ...
Association of lymphopenia rescue and CA19-9 levels with overall survival following IL-15 superagonist N-803 and PD-L1 t-haNK chemo-immunotherapy for 3rd line or greater metastatic pancreatic cancer.
Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing ...
In a recent study published in the journal Nature Communications, researchers investigate the effects of human cytomegalovirus (CMV) reactivation on breast milk composition. Study: Human ...
From the Boeckh, Bradley, and Prlic Labs, a collaboration between the Vaccine and Infectious Disease, Clinical Research, and Public Health Sciences Divisions This project originated when a unique set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results